The Makerere University Anti-Tick Vaccine Project Committee visited Alfasan Uganda Ltd on 24th June 2024 to review the advancements in the Anti-tick vaccine project, particularly focusing on the progress in the establishment of the vaccine production line at Alfasan Uganda Limited. This visit signifies a significant milestone in the ongoing partnership between Makerere University and Alfasan, as they work together towards the creation of a successful Anti-Tick vaccine.
The Principal Investigator (PI) of the Anti-Tick Vaccine Project, Dr. Margaret Saimo-Kahwa welcomed the team and gave a brief overview of the project’s operations. She highlighted Alfasan’s expertise in manufacturing veterinary and human drugs and the suggestion by H.E, the President of Uganda gave in view of the collaboration between Alfasan and Makerere University for the production of the Anti-Tick vaccine. The PI assured team that Alfasan was fully equipped to develop the vaccine in adherence with the standards set by the National Drug Authority.
Dr. Margaret Saimo-Kahwa, PI of the Anti-Tick Vaccine showing the Committee some of the verification equipment at Alfasan.
The Managing Director of Alfasan, Dr. Stephen Birungi said he was delighted to work with Makerere University, where he once studied at the College of Veterinary Medicine, Animal Resources, and Biosecurity (CoVAB). He said a successful collaboration was key in ensuring further advancements and innovations in the field of veterinary medicine.
The Chairperson of Makerere University’s Anti-Tick Vaccine Project Steering Committee, Prof. Henry Alinaitwe emphasized the national significance of the project, and that it was catered for in the national budget. He outlined the division of equipment between Makerere University and Alfasan, stressing the importance of the visit to assess the progress at the Anti-Tick Vaccine production site in Namanve.
The Chairperson of Makerere University Anti-Tick Vaccine Project Committee, who is also the Acting Deputy Vice-Chancellor, Finance and Administration, Prof. Henry Alinaitwe, together with the CoVAB Principal Prof. Frank Norbert Mwiine took a guided tour around the Vaccine Production Facility.
The facility Pharmacist at Alfasan, Mr. Ivan Kafeero provided a brief history of the company, highlighting its transformation from an international collaboration to a prominent private entity in Uganda. The collaboration between Alfasan and Makerere University resulted in the joint production of a laboratory experimental vaccine in 2022, necessitating the facility’s upgrade to accommodate vaccine production alongside pharmaceuticals.
During the tour of the vaccine production facility led by Mr. Kafeero, various departments were showcased, including raw material warehouses, production sections, laboratories, and packaging rooms. The comprehensive tour demonstrated the facility’s readiness for vaccine production and emphasized the critical need for sustainable energy and water sources to support the operations effectively.
The Project Committee and the Project team during the guided tour around the vaccine manufacturing facility led by the facility Pharmacist, Mr. Ivan Kafeero.The Project Committee and the Project team during the guided tour around the vaccine manufacturing facility led by the facility Pharmacist, Mr. Ivan Kafeero.
Following discussions and observations during the visit, the Committee Chairperson commended the progress achieved thus far and confirmed plans for a follow-up visit in two months to monitor the facility’s operational readiness for commencing production.
The collaborative partnership between Makerere University and Alfasan signifies a ground-breaking initiative in animal healthcare research and underscores the potential for significant advancements in combating tick-borne diseases through innovative collaborations and dedicated efforts.
The meeting between Makerere University Anti-Tick Vaccine Project Committee, the Anti-Tick Vaccine Project team, and the Team from Alfasan on 24th June 2024.
On Friday, March 28th, 2025, alumni of molecular biology gathered at Mestil Hotel in Kampala to honor Prof. George William Lubega, a distinguished teacher whose dedication to nurturing scientists has left an indelible mark on Uganda’s scientific community.
The event, organized by the alumni, celebrated Prof. Lubega’s pivotal role in transforming students into leaders in molecular biology. Dr. Claire Mack Mugasa, Dean of the School of Biosecurity, Biotechnical, and Laboratory Sciences at Makerere University, shared heartfelt recollections of Prof. Lubega’s impact, including his scholarship support and passionate teaching style. Dr. Mugasa noted, “The scientists we have in Uganda are a testimony to his boldness. He has been a father to us in science, and now we are fathers of others.”
Prof. Lubega expressed gratitude for the honor and acknowledged the mentorship he received from his teachers. He also highlighted his groundbreaking contributions, including patented vaccines against trypanosomiasis, and thanked Makerere University for providing an enabling environment for scientific advancement.
The event emphasized the importance of continuing his legacy through initiatives like an association of molecular biologists. The alumni expressed their deep appreciation for Prof. Lubega’s selfless efforts, which have transformed the landscape of science education in Uganda.
This celebration stands as a testament to Prof. Lubega’s lasting influence on his students, colleagues, and the scientific community at large.
Makerere University convened a symposium to explore bacteriophage applications in combating antimicrobial resistance (AMR) and addressing health, agricultural, and environmental challenges. Organized by The Alliance for Phage Research and Development Uganda Ltd (PhageTeam Uganda), the event brought together researchers from Makerere University, Kyambogo University, Kampala International University, and Ian Clarke International University, and other players, highlighting a collaborative approach to tackling global and local issues.
Day two of the symposium saw researchers and policy makers together with partners from the UK and USA hold a discourse on the best way forward in the promotion of bacteriophage research and production in the country to support efforts against anti-microbial resistance.
Dr. Jesca Nakavuma, the lead phage researcher from the College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB), gave the background to the workshop.
Speaking at the event held at Hilton Garden Inn, Dr. Jesca Nakavuma, the lead phage researcher from the College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB), Makerere University, stressed the urgent need for alternative antimicrobial agents due to the rise in drug resistance and limited discovery of new antibiotics. Bacteriophages, natural viruses that target bacteria, she said, were identified as a promising solution to revolutionize disease control, treatment, and food security. She said research in this area was key because humankind was at risk of the impending calamity of life-threatening treatment failure.
Prof. Robert Wamala, represented the VC, Prof. Barnabas Nawangwe.
Prof. Robert Wamala, Makerere University‘s Director for Research, Innovations, and Partnerships, who spoke on behalf of the Vice Chancellor, Prof. Barnabas Nawangwe, underscored the importance of building local capacity in phage research. He noted that such efforts could enhance Uganda’s resilience against AMR and yield homegrown solutions for human, animal, and crop health.
As the world grapples with the growing threat of antimicrobial resistance (AMR), bacteriophage research offers a promising alternative. Phages, which are natural enemies of bacteria, have the potential to revolutionize the approach to treatment, disease control, and food security, he noted. He said building local expertise in phage application can enhance Uganda’s resilience against AMR and produce sustainable homegrown solutions to health and environmental challenges.
A section of the stakeholders who participated in the discourse listened attentively.
Prof. Robert Wamala said Makerere University was committed to supporting cutting-edge research and innovation that addresses national and global challenges in line with the university’s role in knowledge generation, technology advancement, and policy influence. The importance of regulatory institutions, he said, cannot be overemphasized in this endeavor, since they enforce compliance, uphold ethical standards, and foster an enabling environment for impactful research and innovation. He said the engagement presented an opportunity to strengthen collaboration between researchers, institutions, and regulatory bodies to ensure that the outcomes are scientifically sound and are aligned to the national development priorities and global best practices.
Dr. Claire M. Mugasa, the Dean of the School of Biosecurity, Biotechnical and Laboratory Sciences (SBLS), CoVAB reiterated the fact that antimicrobial resistance was on the rise in Uganda and Africa, more than elsewhere in the world. She said it was time now that efforts be intensified in looking for sustainable options to curb the dangerous trends. She said this cuts across the human and the animals. She said it was an opportune time for players to come together to find ways of getting the required alternative. She said by coming together, the different ideas developed individually would in a concerted effort, pulling resources together for a way forward.
Dr. Claire M. Mugasa, the Dean of the School of Biosecurity, Biotechnical and Laboratory Sciences (SBLS) addressed the meeting.
During the discourse, several subjects were addressed, including an introduction to antimicrobial resistance, phage biology, phage application, and lessons learnt from the establishment of a phage research centre in the UK, which was presented by Prof. Martha Clokie from the University of Leicester. This initiative reflects a commitment to fostering innovation, collaboration, and regulatory compliance, positioning Uganda as a leader in sustainable solutions for global challenges.
The symposium was sponsored by Global AMR Innovation Fund (GAMRIF), through a grant to the UK Medicines and Healthcare products Regulatory Agency (MHRA) in partnership with Phages for Global Health.
Bacteriophage research and its applications were the focal point of the 1st Symposium on Bacteriophage Research and Applications, convened by Makerere University‘s College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB) on Thursday, March 27, 2025. This landmark event showcased Uganda’s strides in harnessing bacteriophages as innovative solutions to antimicrobial resistance (AMR) and other pressing health and agricultural challenges.
Tobi Elaine Nagel, the President of Phages for Global Health (USA), was one of the presenters.
Key speakers included Dr. Jesca Nakavuma, CoVAB (Makerere University), who showcased Uganda’s pioneering phage research initiatives and vision. Tobi Elaine Nagel, the President of Phages for Global Health (USA), discussed the global significance of phage research. Prof. Martha Clokie, from the University of Leicester’s Centre for Phage Research (UK), shared insights into the latest advancements in phage therapy. Dr. Robert Blasdel, representing VASALE (Belgium), presented innovative solutions using bacteriophages. Ms. Abigail Riggs, from the Foreign, Commonwealth and Development Office (UK), emphasized international partnerships and policy development.
Prof. Robert Wamala, Director, Directorate of Research, Innovation and Partnerships addressed the participants.
Speaking at the event, Prof. Edward Wamala, Makerere University’s Director of Research, Innovation and Partnerships, who represented the Vice Chancellor Prof. Barnabas Nawangwe at the event, highlighted the critical role of bacteriophage research in addressing the global threat of antimicrobial resistance (AMR). He explained how the misuse and overuse of antibiotics in human health, agriculture, and aquaculture have accelerated the emergence of drug-resistant bacterial strains, rendering standard treatments ineffective. Citing statistics from the World Health Organization, he pointed out that AMR claims over 1.3 million lives annually, a number expected to rise without urgent action. He lamented the stagnation of new antibiotic development due to high research costs and rapid bacterial resistance, making bacteriophage therapy a powerful and promising alternative.
A Section of the stakeholders that participated in the engagement.
Prof. Wamala expressed Makerere University’s commitment to advancing research that addresses critical societal challenges, aligning with its mission of generating transformative knowledge and fostering sustainable development. He emphasized Uganda’s potential to lead in bacteriophage research, driven by multi-disciplinary partnerships and capacity building. He also highlighted ongoing studies into aquaculture-specific bacteriophages at CoVAB as an example of how phage technology can revolutionize sectors like agriculture while addressing AMR. Through such efforts, the university aims to position Uganda as a global leader in innovative solutions to combat antimicrobial resistance and enhance public health.
Dr. Jesca Nakavuma, from the College of Veterinary Medicine, Animal Resources, and Biosecurity.
Dr. Jesca Nakavuma, widely regarded as the mother of phages in Uganda, delivered a compelling presentation at the Symposium, where she detailed the impressive progress of phage research in Uganda since its inception in 2017. She highlighted Makerere University’s pioneering efforts, starting with a cohort of five undergraduate students, which have since expanded into groundbreaking research addressing challenges in agriculture, clinical health, food safety, and environmental safety. Key achievements include advancements in E. coli and Salmonella detection, tackling avian colibacillosis, and innovations in decontamination methods, underscoring the transformative potential of phage technology in combating antimicrobial resistance and enhancing public health.
The University leadership included Prof. Robert Wamala (R) and Assoc. Prof. James Acai Okwee (C), Deputy Principal CoVAB.
The symposium honored collaborative efforts, including the establishment and accomplishments of Phage Team Uganda, which developed a repository of 125 characterized phage isolates and trained over 20 PhDs, MScs, and BSc students. Partnerships with international organizations such as IDRC InnoVet AMR and AU Safe Fish have significantly contributed to advancements in antimicrobial resistance and aquaculture.
The participants were actively involved in the discussions.
Despite these achievements, Dr. Nakavuma noted challenges such as insufficient facilities for large-scale phage production, regulatory limitations, and financial constraints. She affirmed that despite the challenges, the team remained ambitious, envisioning the creation of a fully equipped Phage Research and Development Center, the commercialization of phage products, and the establishment of policy frameworks to support the use of phages in Uganda.
The Deputy Principal of CoVAB, Prof. James Acai Okwee, warmly welcomed the partners to the conference and acknowledged their invaluable contributions to the college’s research efforts. He emphasized the importance of collaboration in driving innovation and achieving impactful results, highlighting the pivotal role that partnerships play in fostering academic and scientific growth. Prof. Okwee’s remarks set an encouraging tone for the conference, reinforcing the college’s commitment to advancing research initiatives and creating opportunities for shared learning and development.
Part of the audience at the symposium.
The event that attracted the participation of various stakeholders including academia, civil society, and policy makers, concluded with acknowledgments of the efforts of Phage Team Uganda, collaborators, and funders, setting the stage for an exciting future in Uganda’s journey to combat antimicrobial resistance and ensure food and environmental safety.